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Abstract
Bioluminescence in marine systems is dominated by the use of coelenterazine for
light production. The bioluminescent reaction of coelenterazine is an enzyme catalysed
oxidative decarboxylation: coelenterazine reacts with molecular oxygen to form carbon
dioxide, coelenteramide and light. One such class is the Ca2+-regulated photoproteins.
These proteins bind coelenterazine and oxygen, and trap 2-hydroperoxycoelenterazine,
an intermediate along the reaction pathway. The reaction is halted until Ca2+ bind-
ing triggers the completion of the reaction. There are currently no reported experi-
mental, atomistic descriptions of this ternary Michaelis complex. This study utilised
computational techniques to develop an atomistic model of the Michaelis complex.
Extensive molecular dynamics simulations were carried out to study the interactions
between four tautomeric/protonation states of coelenterazine and wide-type and mu-
tant obelin. Only minor di↵erences in binding modes were observed across all systems.
Interestingly, no basic residues were identified in the vicinity of the N7-nitrogen of
coelenterazine. This observation was surprising considering that deprotonation at this
position is a key mechanistic step in the proposed bioluminescent reaction. This work
suggests that coelenterazine binds either as the O10H tautomer, or in the deprotonated
form. Implicit ligand sampling simulations were used to identify potential O2 binding
and migration pathways within obelin. A key oxygen binding site was identified close
to the coelenterazine imidazopyrazinone core. The O2 binding free energy was observed
to be dependent on the protonation state of coelenterazine. Taken together, the de-
scription of the obelin-coelenterazine-O2 complexes established in this study provides
the basis for future computational studies of the bioluminescent mechanism.
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This study uses computational techniques to develop an atomistic description of the obelin-
coelenterazine-O2 complex. Our results suggests that the binding pocket favours either
the O10H or deprotonated form of coelenterazine, rather than the N7H form as previously
proposed. Additionally, we identified O2 binding sites within the active site, close to the
coelenterazine imidazopyrazinone core. It was observed that O2 binding was generally more
favorable, energetically and geometrically, when coelenterazine was in the O10H form.
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INTRODUCTION
Bioluminescence is arguably one of the most fascinating phenomena in nature. In all cases,
it is the product of a biochemical reaction. The chemical origin of this light contrasts with
other cold forms of light, fluorescence and phosphorescence, which require an absorbance of
light initially in order to emit light. Bioluminescent organisms produce their light through
chemical oxidation of a substrate (luciferin) by an enzyme (luciferase).
The imidazopyrazinones are the most widely used of the known luciferins in marine
bioluminescence, and the most well-characterised classes of bioluminescent substrate along
with the firefly luciferin.1,2 The skeleton structure common to all imidazopyrazinones consists
of a six-membered dihydropyrazine ring fused with a five-membered, dihydroimidazolone
ring, to give the 3,7-dihydroimidazo[1,2-a]pyrazin-3(7H)-one. Coelenterazine (1, Figure 1
(a)) is the most common of all marine luciferins.3 Coelenterazine is unstable in aqueous
solutions and slowly degrades via an auto-oxidation pathway.4,5 In an aprotic medium, such
as dimethyl sulfoxide (DMSO) the reaction proceeds readily.6 Light is emitted as a product of
the reaction of coelenterazine and O2 to give coelenteramide. The general chemiluminescent
reaction mechanism first proposed by McCapral et al.7 and further elaborated on by Goto8
is shown in Figure 1 (b). The reaction is initiated with the dissociation of a proton from
the N7-nitrogen to give anionic coelenterazine (1 ) which reacts readily with O2 at the C2-
carbon to produce the coelenterazine peroxide ion (4 ). The peroxide moiety is a strong
nucleophile and attacks the carbonyl at the C3-position producing the cyclic dioxetanone
(5 ). This is followed by thermal decomposition by decarboxylation to give the oxyluciferin
product, coelenteramide (6 ⇤ or 6⇤), in the singlet excited state.
One special class of bioluminescent luciferases is the Ca2+-regulated photoproteins. These
proteins, rather than continuously processing substrate, bind 2-hydroperoxycoelenterazine
(4) as an intermediate along the reaction pathway. The reaction halts until an external
stimulus (i.e. Ca2+) triggers the continuation of the bioluminescent reaction.9 While photo-
proteins require oxygen for the formation of their active state, they do not require an external
substrate, or a supply of O2 to luminesce like other luciferases. This gives photoproteins their
apparent oxygen independent bioluminescence. The 2-hydroperoxycoelenterazine is formed
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in the predominately hydrophobic binding site through the combination of O2 and coelen-
terazine (Figure 1 b). Each Ca2+-regulated photoprotein has a ( blmax) in the range 465–495
nm.10,11
Obelin from the hydroids of the genus Obelia, a member of Ca2+-regulated photoprotein
family, is among the best known and well-studied luciferases. Obelin is a single chain,
monomeric protein. Its compact globular structure consists of eight helices (labelled A–H in
Figure 2), four pairs of two in a helix-turn-helix motif known as an EF-hand. Two of these
EF-hands (I and II) form the N -terminal and another two EF-hands (III and IV) form the
C -terminal domain. These two domains are roughly cup-shaped and are joined along the
rim forming an internal cavity. The binding pocket and the key residues lining the binding
pocket of obelin are illustrated in Figure 2. This internal pocket is made of hydrophobic
side chains of the residues found within the ↵-helices of the protein. Only six polar residues
extend into the central binding pocket, His22, Trp92, Tyr138, His175, Trp179, and Tyr190,
surrounding the core imidazole ring of coelenterazine and interact with the O10-oxygen. It
is assumed that most of the interactions for coelenterazine are the same as those for the
hydroperoxy-intermediate, observed by X-ray crystallography. His175, Trp179, and Tyr190,
collectively referred as the catalytic triad, are hypothesised to play a role in oxygen activation
and the luminescent reaction. The other key polar residues in the binding site, His22 and
Tyr138 are thought to modulate the protonation state of the emitting amide.
Experiments in the Vysotski laboratory using tryptophan fluorescence quenching of ae-
quorin and obelin determined that coelenterazine binds in the central binding pocket on
the sub-millisecond time scale.12 Apparent dissociation constants for coelenterazine were re-
ported as 0.2 mM for obelin, and 1.8 mM for aequorin. Despite the relatively tight binding of
coelenterazine, no structural data exists of the unmodified coelenterazine in the binding site
of a Ca2+-regulated photoprotein. This is not surprising considering the di culty of trapping
a functional enzyme in complex with its natural substrate. Such conditions would need to
exclude O2 and Ca2+, unless mutations could be made that would remove the catalytic func-
tion of the enzyme without disrupting the binding of coelenterazine. Additional experiments
performed by the Vysotski group examined the role of key residues for the reaction of O2
and coelenterazine. Eremeeva et al.13 made a number of active mutants of obelin and mea-
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sured the apparent dissociation constant of coelenterazine and the apparent rate constant for
the formation of the 2-hydroperoxycoelenterazine in the binding site. The mutants h175n
and y190f showed very similar apparent dissociation constants for coelenterazine, while the
other mutants showed a decreased a nity for coelenterazine. All mutations showed a de-
crease in the apparent rate constant for the formation of 2-hydroperoxycoelenterazine. Since
h175n and y190f showed only a decrease in the apparent rate constant (roughly an order of
magnitude) and a minimal change to the apparent dissociation constant of coelenterazine we
can infer that they play a role converting coelenterazine into 2-hydroperoxycoelenterazine.
It can also be assumed that they play a minor role in the binding of coelenterazine. His175,
perhaps with the assistance of Tyr190, might deprotonate coelenterazine, similar to the Ca2+
triggering mechanism.13 Deprotonation followed by substrate-assisted activation of oxygen is
a common mechanism in cofactor free oxygenases.14 The other mutations, Tyr138 to pheny-
lalanine or tryptophan, and Trp179 to phenylalanine increased the apparent dissociation
constant (decreasing the strength of binding), and decreased the apparent rate constant for
the formation of the 2-hydroperoxycoelenterazine.13 The crystal structures of active obelin
and aequorin show hydrogen bonds of these residues to the 2-hydroperoxycoelenterazine pros-
thetic group. Tyr138 interacts with the N1-position of the imidazopyrazine, and Trp179 with
the carbonyl oxygen. Removal of these hydrogen bonds through substitution with pheny-
lalanine decreases the apparent rate constant for the 2-hydroperoxycoelenterazine formation.
The apparent dissociation constant of coelenterazine also increases. This implies that these
hydrogen bonds are important for the formation of the 2-hydroperoxycoelenterazine pros-
thetic group. There could be a number of mechanisms through which these key residues
influence the rate of active photoprotein formation. They could be involved in position-
ing coelenterazine within the binding pocket for oxygen to position itself optimally for any
orbital overlap required for the proposed single electron transfer step. They could, by modi-
fying the charge distribution, stabilise the one particular tautomer or the deprotonated form
of coelenterazine, in order to provide the favourable protonation state. Alternatively, they
could, by a similar charge perturbation mechanism, shift the reduction potential to be more
energetically favourable.
Past research has focused on the mechanism of Ca2+ triggering or the identity of the
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emitting species, examined the regeneration of aequorin and obelin, and the e↵ects of ad-
ditives, reducing agents, pH and temperature.15–18 In contrast, less is known about the
mechanism of active photoprotein formation and the details of coelenterazine binding (e.g.
its tautomeric and protonation states) and its interactions with O2. To gain a better under-
standing of the atomistic details of the Michaelis complex, we characterised the ternary
obelin-coelenterazine-O2 Michaelis complex. We studied the interactions of the binary,
obelin-coelenterazine complex at an atomistic level, probe oxygen binding sites and migra-
tion pathways within the protein. We investigated both the catalytic triad mutants (h175n,
w179f and y190f) and product protonation mutants (y138f and y138w), as Tyr138 is
involved in hydrogen bonding with the N1-nitrogen of coelenterazine.
METHODOLOGY
Classical force field development for coelenterazine
The force field parameters for coelenterazine at the di↵erent tautomeric and protonation
states (1:(N7H), 1:(O10H) and 1 , Figure 3) were developed. First, the initial force field
parameters were generated based on the CHARMM general force field (CGenFF)19,20 and
then were optimised with the GAAMP method.21 Specifically, the partial atomic charges
and identified “soft” dihedrals, which are not presented in the current CGenFF force field or
have higher penalty scores, were optimised following the standard protocol for the CHARMM
force field. The final force field parameters can be found in Ref.22. Their performances for
the properties including the monohydrate binding energies and the torsional profiles can be
found at SI Table S1 and Figure S1-S2.
Molecular dynamics simulations of the obelin-coelenterazine complexes
For each system the protein and substrate coordinates from the X-ray structure reported by
Deng et al23 (PDB ID: 1sl9, resolution 1.17 Å) were utilised. 1sl9 is an engineered mutant of
wild-type obelin where one of the residues in the Ca2+-binding domain, Ser163 was mutated
to alanine. For the missing loops and residues 1–4 and 123–127, coordinates were generated
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with the online ModLoop utility.24,25 The crystal structure substrate, 2-hydroperoxy coe-
lenterazine, was converted to coelenterazine by manually deleting the peroxide moiety and
adding hydrogen atoms as appropriate for each protonation state of coelenterazine (Figure
3). Protonation of other ionisable groups at pH 7.0 was determined using PROPKA 2.026.
His175 was predicted to be in its neutral form with a neutral coelenterazine. Additionally,
His175 was changed to the protonated form with an ionised coelenterazine (1 ) to probe its
e↵ects on O2 binding.
All MD simulations were performed with CHARMM (version 38a1)27 for the initial setup
and NAMD (version 2.9)28 for the main production runs. The protein and ions were mod-
elled with the all-atom CHARMM force field (version c36)29, water was represented by the
TIP3P model30. For the production run, constant temperature and pressure molecular dy-
namics simulations with periodic boundary conditions were run at 298.15 K and 1 atm. The
temperature and pressure were controlled in the simulation by Langevin dynamics with a
damping constant of 5 ps, and a Noose-Hoover Langevin piston31,32 with a period of 200 fs
and a decay rate of 100 fs. All the bonds involving hydrogen atoms were kept rigid with the
RATTLE algorithm33. Long-range electrostatic interactions were treated with Particle-mesh
Ewald,34 with a real-space cuto↵ of 12 Å. The integration time step was 1 fs, 2 fs, and 4 fs
for bonded, non-bonded and long-range electrostatics, respectively. Coordinates were saved
every picosecond. Each system was run in triplicate. In total, 27 di↵erent systems were
simulated with ⇠4.0 µs, namely, 1sl9, wt, h175n, w179f, y138f, y138w, and y190f in
complex with coelenterazine in four di↵erent tautomeric and protonation states (Figure 3).
Note that there is no ion pair state 1 ·[His175]+ for h175n (see more details in SI).
Analyses of the MD trajectories
Post-simulation analyses were performed with CHARMM27 and VMD35. To monitor global
structural evolution and stability during MD simulations, the root-mean-square deviations
(RMSDs) with respect to the 1sl9 crystal structure and the root-mean-square fluctuations
(RMSFs) around the average position during the simulation were calculated. Central struc-
tures, the individual coordinate set from a MD simulation with the minimal RMSD from the
average structure across the trajectory, were also calculated during the RMSF calculation
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for visualisation.36
Key atomic interactions were analysed with CHARMM (version 38a1)27. Hydrophobic
and hydrogen bonding interactions were defined by geometric criteria. Hydrophobic contacts
were defined by a maximum distance of 4 Å between aliphatic or aromatic carbon atoms
with a minimum 10% occupancy. Hydrogen bonding interactions between the coelenterazine
and obelin were defined by a minimum donor–hydrogen–acceptor angle of 120  and a maxi-
mum heavy atom donor–acceptor distance of 3 Å. Water-mediated (bridged) hydrogen bonds
(DH/A· · ·H2O· · ·DH/A) were defined according to the same geometric criteria. For direct
hydrogen bonds, only those which were occupied for greater than 10% of the simulation
time were considered. For water bridged only those which were occupied over 30% of the
simulation time were considered.
To further evaluate proton acceptors and donors in the neighbourhood of tautomeric acid-
base atoms of the imidazopyrazinone core, the radial distributions functions were calculated
for any hydrogen-bond acceptor (water or polar side chains of amino acids, but not the
backbone) around either the N7–nitrogen or the O10–oxygen of coelenterazine.
Implicit ligand sampling to predict the O2 migration pathways and bind-
ing sites
Implicit ligand sampling (ILS) was performed with the inbuilt algorithm developed by Cohen
et al.37 and implemented in VMD as a part of the volmap utility. Snapshots from every 5
ps were taken from the equilibrium simulations of each of the four tautomeric/protonation
states of coelenterazine and obelin. Frames were aligned to minimise the RMSD of the
C↵ atoms of the protein in each frame with respect to average structure protein across the
duration of the equilibrium simulation. Force field parameters for the O2 probe were used as
supplied in the VMD implementation of ILS.37 The PMF was calculated with a resolution of
1 Å with 20 equally probable orientations of O2 averaged for each voxel, and a non-bonded
cuto↵ of 12 Å.
In ILS the potential of mean force (PMF) of placing a small ligand (in this case O2) at
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a position x is given by








The PMF, W (x), is an ensemble average of the interaction energy, ( E(x, qm,⌦k)), be-
tween ligand and the remaining system taken over all sampled conformations Np and ligand
orientations, Nc. This PMF, while theoretically continuous, is calculated on a discrete 3D
grid. The resulting map describes the binding interactions of O2 through the entire simu-
lated system. Further analysis of this landscape can reveal local minima and the energetic
profile of the minimum energy pathways between them.
The obtained PMF is further converted to the free energy associated with moving O2
from the aqueous phase to the protein binding pocket ( Gwat!prot(O2)). Following the
procedure by Damas et al38, the free energy profiles along the O2 migration paths were
obtained. Briefly, the method partitions the energy landscape into basins through a steepest-
descent tessellation, where a basin is defined as all the points in the map where a steepest
descent path gives the same local minimum. Next, the lowest energy points along the
boundary of two basins are defined as the saddle pair and define the boundary between the
basins.
RESULTS and DISCUSSIONS
Global stability and flexibility of the systems
To the best of our knowledge, there have been no reported MD simulations of coelenter-
azine in the binding pocket of a photoprotein. Additionally, no experimental structures
of unreacted coelenterazine complexed with obelin exist. All crystal structures of hydroid
photoproteins, aequorin and obelin, are either the apo-photoprotein with Ca2+ ions in the
calcium-binding domains,39 photoprotein complexed with the coelenterazine peroxide in-
termediate,40–44 or photoprotein with the reaction product, coelenteramide.42,45,46 The MD
simulations for all simulated systems were stable with respect to the C↵ RMSD (SI Fig-
ure S3 to S9). In all simulations the protein C↵ RMSD converged to between 1.0 and 2.7
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Å, indicating that there was no significant change in the overall structure of the protein.
This similarity is consistent across all tested obelin mutants and the tested coelenterazine
protonation states. Figure 4 shows the residue average RMSFs for the whole protein and
heavy-atom RMSFs for coelenterazine. Residue average RMSFs were consistent across all
protonation states and mutants. All mutants showed a residue average RMSF of approx-
imately 1-2 Å for all residues with the exception of the N-terminal residues and residues
within the Ca2+-binding domains two and three (CBD2 and CBD3).
The ligand remained stable throughout the simulation, as evidenced by the RMSF plots
in Figure 4. This trend was observed for almost all mutants and protonation states. The
R2 group on the C6 carbon remained the most steady with the smallest and most consistent
RMSFs. The imidazopyrazinone core and R3 group were similarly stable across all simulated
systems. Only for the 1sl9-1:(N7H) simulation did we observe any significant deviation.
The observed fluctuation of the R3 group was due to oscillate between two closely related
binding geometries coupled with rotation of the aromatic ring within the binding site.
The only mutant-specific change in the coelenterazine RMSF was observed for the R2
group. For h175n and y190f, 1:(N7H) and 1  simulations were observed to increase in
their mobility, while y138w all protonation states increased in their RMSFs. It is interesting
that changing the hydrogen bonding network surrounding the O10 oxygen increases the
mobility of the most spatially remote side group of coelenterazine. This e↵ect may be due to
a decrease in rigidity in the hydrogen bonding network surrounding the carbonyl oxygen of
coelenterazine, lowering the energetic cost of moving coelenterazine slightly sideways in the
binding pocket. This in turn allows coelenterazine to accommodate slightly more movement
of the R3 group.
The largest RMSF was observed for the N-terminal residues. These are not resolved
in the X-ray structure of obelin,23,43 and as such were expected to be highly mobile in
our simulation. Other regions of larger than average mobility are Ca2+-binding domains
two and three (CBD2 and CBD3). Interestingly the loop containing Ca2+-binding domain
one shows little-to-no additional mobility over the surrounding protein, while the other two
Ca2+-binding domains show far greater mobility. These loop regions were seen to have RSMF
values above 2 Å for all mutants and coelenterazine protonation states. In the case of wild-
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type obelin (wt) and the y138w and y190f mutants Ca2+-binding domain two (CBD2) had
RMSF values in the vicinity of 4 Å, the largest RMSF observed other than the highly mobile
N-terminus. In wild-type obelin (wt), the RMSF of Ca2+-binding domain three (CBD3)
was approximately 3.5 Å, for all other mutants this was around 3 Å.
All the other mutations investigated in this work are in the region between CBD2 and
CBD3, y138f and y138w or after CBD3, the catalytic triad based mutations, h175n,
w179f and y190f. No mutant-specific anomalies were seen in for the catalytic triad and
product protonation based mutants. Moreover, no large di↵erence was seen for the four
di↵erent tautomeric/protonation states either. Only the wild-type wt to 1sl9 mutation
changes a residue in a mobile loop region of the protein. Both CBD2 and CBD3 are more
mobile for the wild-type wt than for 1sl9. Interestingly the introduction of a mutation,
moving from the wild-type wt to 1sl9, in CBD3 increases the mobility of both CBD2 and
CBD3. This behaviour is observed for the 1:(O10) and 1 ·[His175]+ ion pair. A di↵erence
in the mobility of calcium binding domain loops was not seen for the 1:(N7H)-coelenterazine
and deprotonated coelenterazine simulations.
Binding pocket interactions
The coelenterazine binding pocket of obelin is an internal pocket, with no surface exposed to
the surrounding solvent. Overall the majority of residues lining the pocket are hydrophobic,
with the exception of His22, Tyr138, His175, Trp179, and Tyr190 (Figure 2 (d)-(g) and 5
(a)). His22 is positioned in the R2 binding pocket, adjacent to the 6-para-hydroxyl group
of coelenterazine. The other four polar residues reside in or above the plane of the Re face
of the bicyclic ring core. This face is also the direction that O2 needs to add to form the
peroxide observed in the crystal structures.
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Hydrogen bonding in the binding site
Solvation structure in the binding site
As protonation and acid-base chemistry is key to the bioluminescent mechanism, we further
characterised the solvation structure around the N7-nitrogen and the O10-oxygen. Radial
distribution functions showing the density of potential proton acceptors around coelenter-
azine are shown in Figure 8. Specifically, the radial pair distributions were calculated for
the distribution of any hydrogen bond acceptor (water or polar side chains of amino acids)
around either the N7-nitrogen or the O10-oxygen of coelenterazine. For all mutants the sol-
vent structure was essentially unchanged for the N7-nitrogen across all protonation states.
Conversely, we see di↵erences in the O10 radial pair distribution dependant on the mutant
and the protonation state.
The most obvious di↵erence between the N7 and O10 radial pair distribution functions
is their magnitudes. The N7-solvation shell was roughly one fifth the magnitude of the O10
values. In addition, the radius at which any solvent structure becomes apparent was 4–6 Å
for the nitrogen while the oxygen radial distribution had maxima at 2 Å and we observe two
solvent shell peaks before a radius of 4 Å. Small solvent structure peaks were observed for
the N7-nitrogen in the y138w ion pair, and w179f and y170f deprotonated coelenterazine
(1 ) simulations. It is important to note that these two solvent structure features mentioned
above are an order of magnitude smaller than the peaks in the radial distribution function
of the O10-oxygen.
This result is unsurprising upon inspection of the coelenterazine binding pocket in obelin.
The majority of the polarity within the pocket is concentrated around the O10-oxygen. In
contrast, the binding pocket in the vicinity of the N7-nitrogen is hydrophobic. The small
solvent structure peaks around N7-nitrogen observed for the y138w ion pair, and w179f
and y170f deprotonated coelenterazine (1 ) simulations were most likely the result of a
water molecule di↵using through the binding pocket in the space above the plane of the
imidazopyrazinone core. This water molecule would be unable to participate in a proton
transfer as the N7H-hydrogen points away from the rings of the core, in between the hy-
drophobic binding pockets of R2 and R3. This observed solvation structure doesn’t preclude
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the N7-nitrogen from losing its proton to give deprotonated coelenterazine. It does however
suggest that deprotonation of neutral coelenterazine would be more readily achieved at the
O10-oxygen.
For O10-oxygen in wt, 1sl9, and h175n, all had maxima in their radial distributions
for simulation with deprotonated coelenterazine (1 ). For all other mutants, the ion pair
(1 ·[His175]+) simulation gave the largest peaks in the radial distribution. No shift was
observed in the radius of the maxima for any mutation or protonation state. However, all
1:(O10H)-coelenterazine simulations were observed to have a consistently smaller or absent
first peak round 2 Å in their radial distribution, in contrast to the other protonation states.
The second peak of the radial distribution was also smaller for the 1:(O10H) coelenterazine
simulations than those with the other protonation states. This behaviour was seen in the
hydrogen bonding networks in Figure 6 and 7, where 1:(O10H)-coelenterazine simulations
were observed to have fewer hydrogen bonds associated the O10-oxygen.
O2 binding and di↵usion pathways in the obelin-coelenterazine
complexes
O2 binding within the coelenterazine binding pocket
The O2 binding sites identified by the ILS calculations are shown in Figure 9 for 1sl9
and SI Figure S10–S15 for other simulations. The properties for key binding pockets are
compiled in Table 1. Their binding modes and energies are similar among di↵erent obelin
(wild-type vs mutants) and here we will focus on 1sl9. All four tautomeric/protonation
states presented a binding mode above the Re face of the imidazopyrazinone ring (Figure
10). This binding pockets was the closest to the C2 carbon, the site of oxygen addition
during bioluminescence (Figure 1). Across all simulated systems they are fairly consistent
in size with the exception of the ion pair simulation. The free energy wells for these binding
pockets were, for comparison, roughly as deep as those of hemoglobin (-16 kJ mol 1 adjacent
the heme).37 Interestingly this binding site was situated over the top of the six-membered
pyrazinone ring, rather than the imidazole ring, in which the C2 carbon that oxygen will
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add in the reaction is positioned. Previous investigations have calculated the reaction energy
profiles for the addition of O2 to coelenterazine disulfonate, the coelenterazine based luciferin
in the firefly squid, Watasenia scintillans in DMSO.47 The investigators assumed a distance
of 3.13 Å between the C2-carbon and the O2 molecule. Based on our observed location of
the oxygen binding pocket, approximately 2 Å above the pyrazinone ring, this distance in
the binding site of obelin is in fact 4.3–5.7 Å. Future investigations will need to take into
account this di↵erence between the solution and protein luminescence mechanisms.
Additional binding sites were observed adjacent to the coelenterazine R1 functional group
binding pocket and below the O10-oxygen, further towards the protein surface. The latter
binding site is situated below, on the opposite side of the imidazopyrazinone core, to the
proposed catalytic triad, His175, Trp179, and Tyr190.48
While most of binding free energy map does not display a strong dependence on the
protonation state of coelenterazine, the key oxygen binding site above the plane of the coe-
lenterazine core does (Figure 10). It was observed that the 1 ·[His175]+ ion pair surface
is the smallest of the four, indicating reduced favourability for O2 binding here. This could
be due to the binding pocket being slightly compacted, or more rigid, due to the Coulombic
attraction between the coelenterazine anion (1 ) and the [His175]+ cation. This was seen
in Figure 6 and 7, where the hydrogen bonding network surrounding the O10-oxygen was
reduced. The 1 ·[His175]+ ion pair simulation developed a secondary pocket in close prox-
imity to the key O2 binding pocket, just above the imidazole ring of the coelenterazine core,
a finding also observed in the 1  simulation. This binding pocket was slightly further from
the coelenterazine core than the key binding pocket, 7.3 Å in the case of the 1  simulation.
However, the binding free energy in this new pocket was lower than that of the key binding
pocket for all protonation states, with the exception of the 1:(O10H) simulation.
In comparison, the 1:(O10H) isosurfaces encloses the largest volume of the four states
(Figure 10). Moreover, the 1:(O10H) simulation has the lowest minimum energy, indicating
the favourability of this protonation state for O2 binding. The remaining two protonation
states, 1:(N7H) and 1  exhibit similar O2 binding.
For the remainder of the free energy map, all four tautomeric/protonation states gave
very similar results. This is in agreement with the observations that there was no signif-
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icant di↵erence in overall system stability or dynamic fluctuations observed between each
protonation state.
O2 migration pathways
There were four major O2 migration pathways observed in obelin. These began at six distinct
sites on the surface of the protein (Figure 11 and SI Figure S16). Two entry points were
observed on the surface of obelin, in the vicinity of the N7-nitrogen. These are referred to
as E1 and E2 in this work. Collectively we refer to E1 and E2 as the N7 entry points. Entry
point E1 was positioned below the C-terminus, in-between the loop joining EF-hand 3 and
EF-hand 4 and the first ↵-helix of EF hand 1. Entry E2 was positioned below Entry point
E1 relative to the plane of the coelenterazine core, located in the junction between ↵-helix 1
and ↵-helix 2 of EF-hand 1. The next two entry points, E3 and E4 were positioned on the
opposite side of obelin to the N7 entry points. Both entry points are located underneath the
mobile N-terminus and converge to a single larger oxygen binding site positioned between
two ↵-helices. Collectively the E3 and E4 entry points are referred to as the O10 entry
points.
The final two entry points, E5 and E6, are positioned on the surface roughly in-line with
the N1-nitrogen of coelenterazine for E5 and the R2 side-chain for E6. Both of these entry
points are located at the confluence of three ↵-helices, for E5 this is ↵-helix 2 of the first
second and third EF hand, while for for E6 this is ↵-helix 2 of EF-hand 1 and 2, and ↵-helix
1 of EF hand 2. All protonation states agree on the entrances to the internal pathways.
This is shown schematically in Figure 11. Internally all pathways were fairly consistent,
only varying in the magnitude of the energy wells in the oxygen binding pockets discussed
previously.
The six entrances converged at the centre of obelin and formed a U-shape around the
imidazopyrazinone core of coelenterazine with the N7H in the bowl of the U. Internally there
are four major pathways observed for O2 migration. The first is the O10 entry points, E3
and E4. This pathway travels from near the N-terminus on the surface underneath the
core of coelenterazine, till roughly underneath the N7-nitrogen where it joins up with the
N7 pathway. The second is the N7 pathway, the shorter of the migration paths, starting
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at entry points E1 and E2, travelling directly to the key binding site above the plane of
coelenterazine. Third is the N1 pathway, observed to lie in the opposite direction to the N7
pathway, from the key binding site towards the surface of the protein in the direction of the
N1 nitrogen of coelenterazine. The fourth pathway consisted of an o↵shoot to the O10 path,
branching o↵ in roughly the same location as the N7 and O10 pathways merge, travelling in
the direction of the R2 group of coelenterazine to the surface to entry point E6.
Figure 12 shows schematically the energy profile along the O2 migration pathways. Of
note, while it was elected to have a cuto↵ energy of 9.0 kJ mol 1 there were no saddle points
with an energy above that of the solution, i.e 0 kJ mol 1. Each of the protonation states
agrees quantitatively with the others for the majority of the energy profiles. The exception
being the key O2 binding sites surrounding coelenterazine where variation occurred in the
energy of the minima (refer to Table 1). With the exception of the 1:(O10H) simulation,
along each of the pathways the surface binding sites at the entry points were the lowest
energy minima, rather than key binding site. Furthermore, there were multiple low lying
minima along each pathway that may act as energetic traps for O2. These low lying minima
may slow the migration of O2 through obelin. This in turn would reduce the apparent rate
of oxygen activation of coelenterazine. Therefore, our observations are consistent with those
by Eremeeva et al.49, that the long regeneration time of obelin may be a result of both slow
O2 di↵usion dynamics and the single electron transfer chemical step. A recent study showed
that in Alk the barrier for O2 di↵usion out of the active site is substantially larger with the
polarisable AMOEBA force field than that with the non-polarisable AMBER ↵99SB force
field. This indicates that once O2 di↵uses into the active site of Alk, it more than likely
stays inside.50 The e↵ects of explicit polarisation for O2 migration in obelin remain to be
studied.51,52
CONCLUSIONS
In this work, a large set of molecular dynamics simulations were carried out to probed the
interactions of coelenterazine in obelin, a state of Ca2+-regulated photoproteins that to date
has not been experimentally observed. The MD simulations demonstrated that there was no
16
significant change in the global structure of obelin as a result of the mutations investigated.
All the mutations chosen for investigation in this work retained some activity.13,48 At that
atomic level, each mutation perturbed the hydrogen bonding network surrounding coelenter-
azine, but only to the extent that the mutated residue lost its hydrogen bonding capability.
The hydrogen bonding network and the solvent structure surrounding the proposed depro-
tonation sites of coelenterazine was much more closely a↵ected by the protonation state of
coelenterazine than the specific mutant under investigation. Our work suggests that the
mutated residues had a minor e↵ect on the binding of coelenterazine on a structural basis.
Rather, any change in experimentally measured activity is a result of the reduced interactions
of each mutant with coelenterazine. This is evidenced by the change in the binding a nity
of coelenterazine for these mutants.13,49 The reduction in the observed rate of photoprotein
activation probably arises through the mutant perturbing the events following coelenterazine
binding, possibly through direct participation in the bioluminescent reaction.
This study saw no hydrogen bonding interactions for the N7-nitrogen for any simulated
mutants or protonation states. This was a particularly surprising result considering the
proposed deprotonation step in coelenterazine bioluminescence (Figure 1)7,8. Our analysis
seems to suggest that coelenterazine bound as the 1:(O10H) tautomer, or as deprotonated
coelenterazine (1 ). This aligns more closely with the currently proposed bioluminescent
mechanism, i.e. protonation occurs before or during binding, or afterwards from the O10-
oxygen. Importantly, this hydrogen bonding and solvent structure analysis don’t tell us
which tautomer is bound in the active site. It provides us insight into possible interactions
for a particular tautomer the binding site of obelin. To determine which protonation state
was most likely to be bound further work is needed. Ideally a calculation of the pKa of
coelenterazine along with a pKa-shift calculation using a free energy perturbation method
would identify the protonation state of coelenterazine once bound.53–56
Implicit ligand sampling indicates that all four tautomeric/protonation states give similar
potentials of mean force for O2 binding. The key di↵erence between protonation states was
the O2 binding pocket above the plane of the coelenterazine core. This binding pocket was
most favourable for the 1:(O10H) tautomer of coelenterazine, and least favourable for the
1 ·[His175]+ ion pair. Analysis found multiple low lying minima along each of the migra-
17
tion pathways, suggesting that the long regeneration time of obelin may, at least in part, be
a product of slow oxygen di↵usion dynamics. The stable ternary obelin-coelenterazine-O2
complexes established in this study will provide the starting structure for future computa-
tional studies of the bioluminescent mechanism.
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Figure 2: Structure of obelin (PDB ID: 1sl9). (a) Shows the eight helices (A–H) that
make up the compact globular structure of obelin. EF-hands are depicted in red (EF-hand
I), gold (EF-hand II), green (EF-hand III) and blue (EF-hand IV). Also shown are the
flexible loop regions between the helices which contain the Ca2+-binding domains (CBD)
in EF-hands I, III, and IV. CBD1 and CBD3 are shown while CBD2 between helices E
and F is not resolved in the crystal structure. (b) Shows how the helices encase the cen-
tral binding pocket. (c) Depicts the same structure as (b) rotated slightly to show the
C-terminal looping over the top of the coelenterazine binding pocket. This C-terminal
structure contains the key residue Tyr190, which has been implicated in the conversion of
coelenterazine into 2-hydroperoxycoelenterazine and in triggering the luminescent reaction.
2-hydroperoxycoelenterazine is shown in its binding pocket in green. Non-carbon atoms are
coloured red for oxygen and blue for nitrogen. Stereo views of the binding pocket residues
surrounding coelenterazine in obelin (d-g). Binding pocket of (d) R1 2-(para-hydroxybenzyl)
substituent of coelenterazine; (e) R2 6-(para-hydroxyphenyl) substituent of coelenterazine;
(f) R3 8-benzyl substituent of coelenterazine; (g) the residues around the central core and
2-hydroperoxy substituent of coelenterazine in obelin. Coelenterazine is coloured green while
photoprotein residues are depicted in grey. Non-carbon atoms are coloured red for oxygen,




































Figure 3: Modelled protonation states of coelenterazine and His175. (a) 1:(N7H):
the neutral N7-coelenterazine with the neutral His175; (b) 1:(O10H): the neutral O10-
coelenterazine with the neutral His175; (c) 1 : the deprotonated coelenterazine with the
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7C<na3 kYl- `3cC0n3 q3a<3 `Kb7 R8 R$3ICN N0 @3qw jRL `Kb7 R8 ,R3I3NA
j3ayCN3 8Ra 3,@ UaRjRNjCRN cjj3Y $Rq3 N0 8,CN< U<3Y 2,@ `Kb7 ,I,nIj30 8Ra
3,@ cwcj3L 8aRL II j@a33 jaCUIC,j3 cCLnIjCRNc.  jRjI R8 S9z NcY II 8Rna UaRjRNjCRN cjj3c
a3 03UC,j30 8Ra 3,@ LnjNj sCj@ j@3 3u,3UjCRN R8 ?Se9M. s@C,@ RNIw @c j@a33 UaRjRNjCRN
cjj3cY 7Ra II UIRjc. N3njaI MЊA,R3I3Nj3ayCN3. Ϲ- VMЊW Cc c@RsN CN $I,G ICN3c. N3njaI
QϹеA,R3I3Nj3ayCN3. Ϲ- VQϹеW. Cc c@RsN CN a30 ICN3c. 03UaRjRNj30 ,R3I3Nj3ayCN3. ϹĢ . Cc
c@RsN CN $In3 ICN3c. N0 j@3 03UaRjRNj30 ,R3I3Nj3ayCN3AUaRjRNj30 ?CcϹЊφ. ϹĢ Ȁ )?CcϹЊφ*Z
. CRN UCa Cc c@RsN sCj@ <RI0 ICN3cY 7Ra 3,@ UaRj3CN `Kb7 j@3 Lnjj30 a3cC0n3 Cc @C<@A
IC<@j30 $w  <a3w a3,jN<I3. s@CI3 j@3 j@a33 +ИZA$CN0CN< 0RLCNc. $$a3qCj30 c B. BB. N0
BBB. a3 c@RsNY 7Ra ,R3I3Nj3ayCN3 j@3 8Rna LCN c3,jCRNc. j@3 CLC0yRUwayCNRN3 ,Ra3 N0
j@3 j@a33 `A<aRnUc. a3 NNRjj30 RN j@3 UIRjcY
Figure 4: Residue average RMSF of obelin and heavy-atom RMSF of coelenterazine for each
protonation state. Each RMSF calculated for each system from all three triplicate simula-
tions. For each protein RMSF, the mutated residue is highlighted by a grey rectangle, while
the three Ca2+-binding domains, abbreviated as I, II, and III, are shown. For coelenterazine
the four main sectio s, the imidazopyrazinone core and the three R-groups, are annotated on
the plots. All four tautomeric/protonation states are depicted for each mutant with the ex-
ception of H175N, which only has three protonation states. For all plots, 1:(N7H) is shown
in black lines, 1:(O10H) is shown in red lines, 1  is shown in blue lines, and 1 ·[His175]+


































































Figure 5: (a) Perspective schematic of coelenterazine showing its position in the binding
pocket of obelin. Heteroatoms are numbered in red and the Re and Si faces with respect
to the prochirality of the C2 carbon are labelled. Hydrogen bonding interactions for all
hydrophilic pocket residues are shown. All other residues within the pocket are hydrophobic.
(b) Hydrogen bonding interactions in 1sl9. Residues mutated in this work are shown in red,
waters are shown in blue, dashed lines indicate hydrogen bonds. Numbers are the donor-




















































































7C<na3 kYf- F3w @w0aR<3N $RN0CN< CNj3a,jCRNc $3js33N ,R3I3Nj3ayCN3 N0 j@3
SbHOAri N0 j@3 ,jIwjC, jaC0 LnjNjc R8 R$3ICNY $Rq3 N0 8,CN< U<3Y ?w0aR<3N
$RN0CN< CNj3a,jCRNc s3a3 ,I,nIj30 8Ra 3,@ cwcj3L 8aRL II j@a33 jaCUIC,j3 cCLnIjCRNc.
 jRjI R8 S9z NcY 2,@ UaRjRNjCRN cjj3 Cc 03UC,j30 c3Uaj3Iw- VW. MЊ?A,R3I3Nj3ayCN3.
Ϲ- VMЊ?Wd V$W. QϹе?A,R3I3Nj3ayCN3. Ϲ- VQϹе?Wd V,W. 03UaRjRNj30 ,R3I3Nj3ayCN3. ϹĢ d N0
V0W. j@3 03UaRjRNj30 ,R3I3Nj3ayCN3. ϹĢ Ȁ )?CcϹЊφ*Z . CRN UCaY bRIC0 ICN3c CN0C,j3  @wA
0aR<3N $RN0 $3js33N j@3 jRL R8 ,R3I3Nj3ayCN3 N0 j@3 CN0C,j30 a3cC0n3Y ?w0aR<3N
$RN0CN< CNj3a,jCRNc 8Ra 3,@ LnjNj a3 c@RsN CN  0C883a3Nj ,RIRnaY #Rj@ SbHO N0 sCI0A
jwU3 cCLnIjCRNc s3a3 ,RL$CN30 8Ra j@3 UnaURc3 R8 j@3c3 N3jsRaG <aU@c c j@3Ca $CN0CN<
UR,G3jc s3a3 C03NjC,IY i@3 SbHOgri CNj3a,jCRNc a3 c@RsN CN $I,G. ?Se9M CNj3a,jCRNc
a3 c@RsN CN a30. rSeO7 CNj3a,jCRNc a3 c@RsN CN $In3. N0 vSOz7 CNj3a,jCRNc a3 c@RsN
CN <RI0Y rj3a LRI3,nI3c 8Ra $aC0<30 @w0aR<3N $RN0CN< CNj3a,jCRNc a3 CN0C,j30 c 
$In3 ȒrȓY  ,njR88 R8 SzX N0 kzX sc UUIC30 jR 0Ca3,j N0 sj3a $aC0<30 CNj3a,jCRNc
a3cU3,jCq3IwY ?w0aR<3N $RN0CN< CNj3a,jCRNc $3IRs j@3c3 j@a3c@RI0c s3a3 NRj ,RNcC03a30Y
BN0CqC0nI R,,nUN,C3c 8Ra 3,@ @w0aR<3N $RN0 a3 j$nIj30 CN UU3N0Cu Y
Figure 6: Key hydrogen bonding interactions between coelenterazine and wt and the cat-
alytic triad mutants of obelin. (a) 1:(N1H); (b) 1:(O10H); (c) 1 ; (d) 1 ·[His175]+.
Solid lines indicate a hydrogen bond between the atom of coelenterazine and the indicated
residue. Hydrogen bonding interactions for each mutant are shown in a di↵erent colour.
Both 1sl9 and wt simulations were combined for the purpose of these network graphs as
their binding pockets were identical. The 1sl9/wt int ractions are hown in black, h175n
interactions are shown in red, w179f interactions are shown in blue, and y190f interactions
are shown in gold. Water molecules for bridged hydrogen bonding interactions are indicated


















































































7C<na3 kYe- F3w @w0aR<3N $RN0CN< CNj3a,jCRNc $3js33N ,R3I3Nj3ayCN3 N0 j@3
SbHOgri N0 j@3 UaR0n,j UaRjRNjCRN cjj3 LnjNjc R8 R$3ICNY $Rq3 N0 8,CN<
U<3Y ?w0aR<3N $RN0CN< CNj3a,jCRNc s3a3 ,I,nIj30 8Ra 3,@ cwcj3L 8aRL II j@a33
jaCUIC,j3 cCLnIjCRNc.  jRjI R8 S9z NcY 2,@ UaRjRNjCRN cjj3 Cc 03UC,j30 c3Uaj3Iw-
VW. MЊ?A,R3I3Nj3ayCN3. Ϲ- VMЊ?Wd V$W. QϹе?A,R3I3Nj3ayCN3. Ϲ- VQϹе?Wd V,W. 03UaRjRNj30
,R3I3Nj3ayCN3. ϹĢ d N0 V0W. j@3 03UaRjRNj30 ,R3I3Nj3ayCN3. ϹĢ Ȁ )?CcϹЊφ*Z . CRN UCaY bRIC0
ICN3c CN0C,j3  @w0aR<3N $RN0 $3js33N j@3 jRL R8 ,R3I3Nj3ayCN3 N0 j@3 CN0C,j30
a3cC0n3Y i@3 @w0aR<3N $RN0CN< CNj3a,jCRNc 8Ra 3,@ LnjNj a3 c@RsN CN  0C883a3Nj ,RIRnaY
#Rj@ SbHO N0 sCI0AjwU3 cCLnIjCRNc s3a3 ,RL$CN30 8Ra j@3 UnaURc3 R8 j@3c3 N3jsRaG
<aU@c c j@3Ca $CN0CN< UR,G3jc s3a3 C03NjC,IY i@3 SbHOgri CNj3a,jCRNc a3 c@RsN CN
$I,G. vSk47 CNj3a,jCRNc a3 c@RsN CN a30. N0 vSk4r CNj3a,jCRNc a3 c@RsN CN $In3Y
rj3a LRI3,nI3c 8Ra $aC0<30 @w0aR<3N $RN0CN< CNj3a,jCRNc a3 CN0C,j30 c  $In3 ȒrȓY 
,njR88 R8 SzX N0 kzX sc UUIC30 jR 0Ca3,j N0 sj3a $aC0<30 CNj3a,jCRNc a3cU3,jCq3IwY
?w0aR<3N $RN0CN< CNj3a,jCRNc $3IRs j@3c3 j@a3c@RI0c s3a3 NRj ,RNcC03a30Y BN0CqC0nI
R,,nUN,C3c 8Ra 3,@ @w0aR<3N $RN0 a3 j$nIj30 CN UU3N0Cu Y
Figure 7: Key hydrogen bonding interactions between coelenterazine and the wt and the
product protonation state mutants of obelin. (a) 1:(N1H); (b) 1:(O10H); (c) 1 ; (d)
1 ·[His175]+ Solid lines indicate a hydrogen bond between the tom of coelenterazine and
the indicated residue. The hydrogen bonding i teractions for each muta t re shown in
a di↵erent colour. Both 1sl9 and wt simulations were combined for the pu pose of these
network graphs as their binding pockets were identical. The 1sl9/wt interactions are shown
in black, y138f interactions are shown in red, and y138w interactions are shown in blue.
Water molecules for bridged hydrogen bonding interactions are indicated as a blue “W”.
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7C<na3 kY4- $Rq3 N0 8,CN< U<3Y i@3 a0CI UCa 0CcjaC$njCRN 8Ra @w0aR<3N $RN0
,,3UjRac CN j@3 qC,CNCjw R8 j@3 MЊANCjaR<3N N0 QϹеARuw<3N R8 ,R3I3Nj3ayCN3Y II
8Rna UaRjRNjCRN cjj3c a3 03UC,j30 8Ra 3,@ LnjNj sCj@ j@3 3u,3UjCRN R8 ?Se9M. s@C,@
RNIw @c j@a33 UaRjRNjCRN cjj3cY 7Ra II UIRjc. N3njaI MЊA,R3I3Nj3ayCN3. Ϲ- VMЊW Cc c@RsN
CN $I,G ICN3c. N3njaI QϹеA,R3I3Nj3ayCN3. Ϲ- VQϹеW. Cc c@RsN CN a30 ICN3c. 03UaRjRNj30
,R3I3Nj3ayCN3. ϹĢ . Cc c@RsN CN $In3 ICN3c. N0 j@3 03UaRjRNj30 ,R3I3Nj3ayCN3AUaRjRNj30
?CcϹЊφ. ϹĢ Ȁ )?CcϹЊφ*Z . CRN UCa Cc c@RsN sCj@ <RI0 ICN3cY MRj3 j@3 0C883a3Nj c,I3c RN j@3
wAu3c 8Ra MЊ N0 QϹеY i@3 MЊ NCjaR<3N wAuCc Cc 9 jCL3c cLII3a CN aN<3 j@N j@3 QϹе
Ruw<3NY
Figure 8: The radial distribution functions for hydrogen bond acceptors in the vicinity of
the N7-nitrogen and O10-oxygen of coelenterazine. All four tautomeric/protonation states
are depicted for each mutant with the exception of H175N, which only has three protonation
states. For all plots, 1:(N7H) is shown in black lines, 1:(O10H) is shown in red lines,1  is
shown in blue lines, and 1 ·[His175]+ is shown with gold lines.
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Figure 9: The key oxygen binding sites identified in 1sl9. Pictured is the -10.0 kJ mol 1
binding free energy surface for each of the simulated protonation states. Two di↵erent
orientations are shown. (a): the 1:(N7H) state; (b): the 1:(O10H) state; (c): the 1 
state; (d): the 1 ·[His175]+ ion pair state.
34
Figure 10: Comparison of the key oxygen binding site by tautomeric and protonation state
in 1sl9. Pictured is the -10.0 kJ mol 1 binding free energy surface for each of the simulated
protonation states, the 1:(N7H) state in white, the 1:(O10H) state in red, the 1  state
in blue, and the 1 ·[His175]+ ion pair in yellow. It is apparent that the 1 ·[His175]+ ion
pair surface is much smaller than the other three protonation states, while the 1:(O10H)





Figure 11: Identified entry points for O2 migration in 1sl9. The predicted entry sites were
consistent across each modelled tautomeric/protonation state. The entry sites are depicted in
(a) for sites E1 and E2, (b) for sites E3 and E4, (c) for site E5, and (d) for site E6. Shown are
the -5.0 kJ mol 1 energy isosurfaces for each tautomeric/protonation states, colour coded as































































































































































































































































































































































































































































































































































































































































































































































































Table 1: The binding free energies for the identified pockets for O2 in obelin. Refer to Figure
9 and Figure S10–S15 for the locations of these binding pockets.
System Free energy/kJmol−1
Protein Protonation A B C D E F
1sl9 1:(N7H) −12.1a −15.3
1:(O10H) −20.7a −10.1b
1  −12.8a −18.2b −15.7
1 ·[His175]+ −10.5a −15.7b −19.6
wt 1:(N7H) −14.5a −11.4 −12.4
1:(O10H) −16.2a −13.1b −12.3
1  −11.6a −16.6b −16.0 −15.2
1 ·[His175]+ −17.2a −13.4b −11.7 −13.3
y138f 1:(N7H) −13.9 −11.8 −18.1
1:(O10H) −16.1a −17.1b −12.5
1  −13.4a −19.0b −12.0
1 ·[His175]+ −10.3a −18.5b −17.3
y138w 1:(N7H) −11.6a −13.1b −14.0 −17.6 −18.5b −12.5
1:(O10H) −19.4a −15.0a
1  −11.2a −14.3 −14.6 −20.8b
1 ·[His175]+ −13.1a −14.4b −13.6 −13.6
h175n 1:(N7H) −16.2a
1:(O10H) −13.8 −10.8a,b −11.5 −18.4
1  −14.7a −10.9b −13.9
w179f 1:(N7H) −15.4a −14.2b −15.9 −15.2
1:(O10H) −19.0a −14.1b −14.1
1  −14.3a −17.2b −14.8
1 ·[His175]+ −18.0a −17.3b −17.3
y190f 1:(N7H) −13.1a −12.9b −19.8 −16.2
1:(O10H) −16.2a −18.1b −18.2 −16.0
1  −14.6 −17.0b −11.6 −12.4
1 ·[His175]+ −10.3a −11.8 −11.8
a Primary binding site, situated immediately above the plane of the imidazopyrazinone ring system of coe-
lenterazine.
b Alternate binding site, situated above the C2 carbon of coelenterazine, towards R1.
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1 The developed force field parameters for coelenterazine
The CGenFF generated parameters were further refined with the GAAMP1. Consistently
with the general philosophy in developing CHARMM and CGenFF force field parameters,
GAAMP can automatically generate the parameters of the atomic moldes of small molecules
using the properties from ab initio calculations as target data. Briefly, the partial charges
have been optimized on the basis of QM electrostatic potential and the monohydrate inter-
action energies at the level of HF/6-31G* (with the target data scaled or shiftted following
the CHARMM force field). The identified soft dihedrals are parametrized by targeting QM
dihedral scans as well as the energies of stable conformers at the level of at HF/6-31G*.
The developed force field parameters for the di↵erent tautomeric and protonation states for
coelenterazine (1:(N7H), 1:(O10H) and 1 ) can be found at Ref.2.
The monohydrate binding energies
The monohydrate binding energies were included during the parameterisation process in
the GAAMP method.1 The stable conformers identified are shown in Figure S1. Their
corresponding binding energies together with the target QM values are shown in Table S1.
The torsional profiles for the “soft” dihedrals
The “soft” dihedrals indentified in the GAAMP method were reparameterised and fitted to
the QM profile (Figure S2). The GAAMP parameters predict each QM dihedral profile with
a MUE in the range 0.1 to 2.5 kJ mol 1.
2 Summary of the simulated systems
The protein-coelenterazine complex was solvated by superimposing the protein with a 65
⇥ 65 ⇥ 65 Å, pre-equilibrated box of water and deleting water molecules that overlapped
with the protein. Each box was neutralised with Na+ or Cl  ions. Further Na+ or Cl 
ions were added to produce an overall salt concentration approximating 150 mM. Before
starting any simulation with these coordinate the system was minimised with a harmonic
2
Table S1: The monohydrate properties for coelenterazine with the developed force field
parameters in comparison with those from the QM calculations. a QM Emin is scaled by a
constant 1.16 for neutral molecules; b QM Rmin is shifted by -0.15Å for neutral molecules and
-0.05Å for charged ones; c MSE is mean signed error and Sse is sample standard deviation
in MSE; d MUE is mean unsigned error and Sse is sample standard deviation in MUE;
e MAXUE is maximum unsigned error. See Figure S1 (a)-(c) for schematic of hydrogen
bonding and (d) for atom numbering.
 Emin/kJ mol 1 Rmin/Å
Molecule Interaction QMa MM   E QMb MM   E
1:N7H N7H · · ·OH2  23.7  17.4 6.3 1.98 2.63 0.65
O19H· · ·OH2  37.4  32.2 5.2 1.82 1.83 0.01
O26H· · ·OH2  33.1  30.7 2.3 1.84 1.83  0.01
N1 · · ·HOH  27.9  24.9 3.0 1.97 1.98 0.01
N7 · · ·HOH  17.0  17.2  0.2 2.78 2.09  0.68
O10 · · ·HOH  29.7  34.1  4.4 1.84 1.74  0.10
O19 · · ·HOH  19.2  19.0 0.2 1.94 1.89  0.05
O26 · · ·HOH  21.4  19.5 1.8 1.92 1.88  0.04
MSE (Sse)c -1.8±3.4 0.03±0.36
MUE (Sse)d 2.9±2.3 0.20±0.29
MAXUEe 6.3 0.68
1:O10H O10H· · ·OH2  39.8  39.4 0.4 1.70 1.75 0.04
O19H· · ·OH2  35.0  33.8 1.2 1.79 1.81 0.02
O26· · ·OH2  32.6  31.5 1.1 1.80 1.82 0.02
N7· · ·HOH  21.9  21.6 0.3 2.15 2.27 0.12
O10· · ·HOH  18.7  19.9  1.2 1.91 1.88  0.03
O19· · ·HOH  19.9  19.7 0.2 1.88 1.87  0.01
O26· · ·HOH  21.1  20.8 0.3 1.87 1.86  0.01
MSE (Sse)c -0.34 ±0.8 -0.02±0.05
MUE (Sse)d 0.68 ±0.5 0.04±0.04
MAXUEe 1.2 0.12
1  O19H· · ·OH2  20.1  19.0 1.1 1.99 1.95  0.04
O26H· · ·OH2  18.3  17.6 0.7 2.00 1.97  0.04
N1· · ·HOH  36.5  34.8 1.6 1.98 1.96  0.02
O10· · ·HOH  48.9  50.0  1.0 1.80 1.70  0.10
O19· · ·HOH  23.9  25.4  1.5 2.00 1.87  0.13
O26· · ·HOH  26.2  28.2  2.0 1.99 1.86  0.13
MSE (Sse)c 0.2±1.5 0.08±0.05
MUE (Sse)d 1.33±0.5 0.05±0.05
MAXUE e 2.0 0.13
3
Figure S1: The monohydrate conformers included in the parameterisation process. (a)
The interactions between water and 1:(N7H); (b) The interactions between water and
1:(O10H); (c) The interactions between water and 1 ; (d) The atom number nomenclature
used in this work.
force constant of 2.0 kcal/mol/Å2 as a restraint on the backbone of the protein and heavy
atoms of coelenterazine. A 10 ps molecular dynamics simulation then allowed the solvent
molecules to relax. These final coordinates were used as the starting point for all simulations
in this investigation. The final system consisted of ⇠28,000 atoms.
The starting structures for the other mutants, h175n, w179f, y138f, y138w, y190f
and wild-type (wt) obelin, were based on the final coordinates of the 1sl9 MD simulation
for each protonation state. To generate the starting coordinates for each mutant these
coordinates were taken and first the s163a mutation engineered for crystal structure 1sl9
was reversed to give wild-type obelin. Then, for all other mutants the appropriate side chains
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were mutated in the wild-type structure to give the required sequence. This means that
with respect to 1sl9, h175n, w179f, y138f, y138w, y190f are all double mutants. All
mutations and structure manipulations were completed with CHARMM.3 After each side-
chain was changed to give the specific mutant, a two step energy minimisation was performed
to remove any introduced steric clashes. All atoms other than the mutated residue were
restrained with a 200.0 kcal/mol/Å2 harmonic restraint, followed by 1,000 steps of steepest
decent minimisation. After this initial minimisation all harmonic restraints were removed
and 2,000 steps of steepest descent energy minimisation was done. These geometries then
were used for the subsequent MD simulations.
All MD simulations were performed with CHARMM (version 38a1)3 during the initial
simulation setup and NAMD (version 2.9)4 for the main production runs. The protein
and ions were modelled with the all-atom CHARMM force field, version c365, water was
represented by the tip3p model,6. MD simulations were then carried out in two phases; first,
a step-wise heating where a decreasing harmonic constraint was applied to the backbone of
the protein while allowing the rest of the system to move freely; second, a propagation step
with no restraints on any of the atoms.
For 1sl9 two seperate stepwise heating steps (4 ns + 4 ns) were performed: the first
for the modelled loops of residues missing from the crystal structure and the second for the
whole protein and ligand. The first stepwise heating consisted of a gradually decreasing
harmonic constraint applied to the modelled loops while the remaining protein and ligand
were restrained with a constant 8.0 kcal/mol/Å2 harmonic restraint. The second stepwise
heating was performed by applying a gradually decreasing harmonic constraint to the Ca of
obelin and the non-hydrogen atoms of coelenterazine while allowing the rest of the system
to move freely. To achieve a gradually decreasing harmonic constraint, a decreasing force
constant was applied to the respective atoms, starting at 8.0–1.0 kcal/mol/Å2 and decreasing
over 4 ns. The decrease in strength of the restraints was achieved gradually by halving the
force constant for each respective 1 ns interval until a force constant of 1.0 kcal/mol/Å2
was obtained (i.e. 8.0, 4.0, 2.0, and 1.0 kcal/mol/Å2). For all other protein systems the
stepwise heating process was identical to that of 1sl9 except that the first step-wise heating
for the modelled loops was skipped and only 4 ns of stepwise heating was performed. The
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second phase of the MD simulations was carried out for 50 ns with no restraints. To obtain
di↵erent starting coordinates for each replicate we used di↵erent initial minimisation steps for
each replicate and initiated each replicate molecular dynamics run with di↵erent velocities.
Four di↵erent tautomeric and protonation states were simulated for each protein, namely,
1:(N7H), 1:(O10H), 1 , and 1 ·[His175]+. So in total, 27 systems were simulated (note
that H175N has three di↵erent states) and accumulatively ⇠4 µs simulation trajectories
were collected.
3 Implicit ligand sampling
Implicit ligand sampling provides a PMF map, which is relative to the isolated O2 molecule
in the gas phase. This refers to the free energy cost of moving an isolated O2 from in
the vacuum to a specific point within the simulated system. In our case, the landscape
of interest was the free energy associated with moving O2 from the aqueous phase to the
protein  Gwat!prot(O2) (i.e. the relative binding free energy  Gbinding(O2)). To convert
the maps, the method outlined in Ref.7 was undertaken. A simulation of O2 in a water box is
performed. These MD simulations were for a duration of 26 ns. ILS was done on snapshots
from every 20 ps, taken from the final 25 ns trajectories. The resulting 3D landscape was
ensemble averaged over every grid point to give a final value of  GS(O2) of 3.4 KBT , or
8.6 kJ mol 1 at 298.15 K. This value was then subtracted from every point in the PMF
map to give the map  Gbinding(O2) in obelin. By using this method, rather than simply
subtracting the experimental free energy of solvation, provides for cancellation of potential
systematic errors associated with the ILS method or force field parameters. That said, the
value obtained via this method for GS(O2), 8.6 kJ mol 1, agreed well with the experimental
value, 8.2 kJ mol 1.
To extract the energy profiles along the O2 migration paths, we used the method devel-
oped by Damas et al.7 The source code of the analysis software was kindly provided by the
authors. The software was subsequently modified by the author of this work to fit into our
workflow using VMD for ILS analysis. Briefly, the method partitions the energy landscape
into basins through a steepest-descent tessellation, where a basin is defined as all the points
6
in the map where a steepest descent path gives the same local minimum. Next, the lowest
energy points along the boundary of two basins are defined as the saddle pair and define the
boundary between the basins. From these saddle points it is trivial to connect minima to
generate paths from one basin to another basin. ILS calculations provide exhaustive sam-
pling over the entire simulated system. A cuto↵ of 8.8 kJ mol 1 was used in the energy
landscape analysis. This is the numerical value of the experimental heat capacity of O2 at
constant pressure at 298.15 K, 8.756 kJ mol 1 K 1, which we use as a proxy for the max-
imum barrier height O2 would be expected to cross due to thermal energy. No transitions
between minima were considered if the absolute energy of the barrier was above this value.
4 Stability of the simulated systems
RMSD for C↵ with respect to the initial structures in the simulations
For each tautomeric and protonation state across the production simulation for each repli-
cate, RMSD was calculated after the C↵ of each frame from the simulation were aligned
to each to the C↵ of the obelin crystal structure, PDB ID: 1sl9, excluding the ModLoop
built missing residues: 1–4 and 123–127. Each RMSD is shown with all data in the lighter
colour, with a 1 ns rolling average overlaid in the darker colour. The y-axis runs from 0 to








































































































Figure S2: The dihedrals fitted for coelenterazine. (a) 1:(N7H): N1–C2–C11–C20 ( 1),
C5–C6–C12–C14 ( 2), and N7–C8–C13–C27 ( 3); (b) 1:(O10H): N1–C2–C11–C20 ( 1),
N7–C6–C12–C14 ( 2), and N7–C8–C13–C27 ( 3); (c) 1  : N1–C2–C11–C20 ( 1), C5–C6–
C12–C14 ( 2), and N7–C8–C13–C27 ( 3). (d), (e), and (f) show the original CGenFF/AM1-
BCC (black), QM (red), and the GAAMP (blue) energy profile for the three fitted dihedrals.
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7C<na3 YS- `Kb/ R8 j@3 +­ jRLc CN SbHOY 7Ra 3,@ UaRjRNjCRN cjj3 ,aRcc j@3 9z Nc
R8 cCLnIjCRN 8Ra 3,@ a3UIC,j3Y `Kb/ sc ,I,nIj30 8j3a j@3 +­ R8 3,@ 8aL3 8aRL
j@3 cCLnIjCRN s3a3 ICN30 jR 3,@ jR j@3 +­ R8 j@3 3uU3aCL3NjI R$3ICN ,awcjI cjan,jna3.
T/# B/- SbHO. 3u,In0CN< j@3 KR0HRRU 8Cjj30 LCccCN< a3cC0n3c- SĢ: N0 SlkĢSleY QNIw
j@3 nN,RNcjaCN30 UaR0n,jCRN anNc a3 c@RsNY 2,@ `Kb/ Cc c@RsN sCj@ II 0j CN j@3
IC<@j3a ,RIRna. sCj@  S Nc aRIICN< q3a<3 Rq3aIC0 CN j@3 0aG3a ,RIRnaY i@3 wAuCc anNc
8aRL z jR j@3 LuCLnL `Kb/ 8Ra j@j cY
Figure S3: RMSD of the C↵ atoms in 1sl9.
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7C<na3 Yl- `Kb/ R8 j@3 +­ jRLc CN sCI0jwU3 R$3ICNY 7Ra 3,@ UaRjRNjCRN cjj3
,aRcc j@3 9z Nc R8 3,@ a3UIC,j3Y `Kb/ sc ,I,nIj30 8j3a j@3 +­ R8 3,@ 8aL3 8aRL
j@3 cCLnIjCRN s3a3 ICN30 jR 3,@ jR j@3 +­ R8 j@3 3uU3aCL3NjI R$3ICN ,awcjI cjan,jna3.
T/# B/- SbHO. 3u,In0CN< j@3 KR0HRRU 8Cjj30 LCccCN< a3cC0n3c- SĢ: N0 SlkĢSleY QNIw
j@3 nN,RNcjaCN30 UaR0n,jCRN anNc a3 c@RsNY `Kb/ Cc c@RsN sCj@ II 0j CN j@3 IC<@j3a
,RIRna. sCj@  S Nc aRIICN< q3a<3 Rq3aIC0 CN j@3 0aG3a ,RIRnaY i@3 wAuCc anNc 8aRL z jR
j@3 LuCLnL `Kb/ 8Ra j@j cCLnIjCRNY
Figure S4: RMSD of the C↵ atoms in wt.
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7C<na3 Yk- `Kb/ R8 j@3 +­ jRLc CN vSk47Y 7Ra 3,@ UaRjRNjCRN cjj3 ,aRcc j@3
9z Nc R8 3,@ a3UIC,j3Y `Kb/ sc ,I,nIj30 8j3a j@3 +­ R8 3,@ 8aL3 8aRL j@3
cCLnIjCRN s3a3 ICN30 jR 3,@ jR j@3 +­ R8 j@3 3uU3aCL3NjI R$3ICN ,awcjI cjan,jna3. T/#
B/- SbHO. 3u,In0CN< j@3 KR0HRRU 8Cjj30 LCccCN< a3cC0n3c- SĢ: N0 SlkĢSleY QNIw j@3
nN,RNcjaCN30 UaR0n,jCRN anNc a3 c@RsNY `Kb/ Cc c@RsN sCj@ II 0j CN j@3 IC<@j3a
,RIRna. sCj@  S Nc aRIICN< q3a<3 Rq3aIC0 CN j@3 0aG3a ,RIRnaY i@3 wAuCc anNc 8aRL z jR
j@3 LuCLnL `Kb/ 8Ra j@j cCLnIjCRNY
Figure S5: RMSD of the C↵ atoms in y138f.
11
رذت
































































7C<na3 Y:- `Kb/ R8 j@3 +­ jRLc CN vSk4rY 7Ra 3,@ UaRjRNjCRN cjj3 ,aRcc j@3
9z Nc R8 3,@ a3UIC,j3Y `Kb/ sc ,I,nIj30 8j3a j@3 +­ R8 3,@ 8aL3 8aRL j@3
cCLnIjCRN s3a3 ICN30 jR 3,@ jR j@3 +­ R8 j@3 3uU3aCL3NjI R$3ICN ,awcjI cjan,jna3. T/#
B/- SbHO. 3u,In0CN< j@3 KR0HRRU 8Cjj30 LCccCN< a3cC0n3c- SĢ: N0 SlkĢSleY QNIw j@3
nN,RNcjaCN30 UaR0n,jCRN anNc a3 c@RsNY 2,@ `Kb/ Cc c@RsN sCj@ II 0j CN j@3 IC<@j3a
,RIRna. sCj@  S Nc aRIICN< q3a<3 Rq3aIC0 CN j@3 0aG3a ,RIRnaY i@3 wAuCc anNc 8aRL z jR
j@3 LuCLnL `Kb/ 8Ra j@j cCLnIjCRNY
Figure S6: RMSD of the C↵ atoms in y138 .
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زذت

















































 KnjjCRN R8 ?CcϹЊφ jR a<CNCN3 L3Nc j@j j@3 ϹĢ Ȁ )?CcϹЊφ*Z CRN Ua Cc NRj URccC$I3Y QNIw j@3 j@a33
UaRjRNjCRN cjj3c R8 ,R3I3Nj3ayCN3 s3a3 anNY
7C<na3 Y9- `Kb/ R8 j@3 +­ jRLc CN ?Se9MY 7Ra 3,@ UaRjRNjCRN cjj3 ,aRcc j@3
9z Nc R8 3,@ a3UIC,j3Y `Kb/ sc ,I,nIj30 8j3a j@3 +­ R8 3,@ 8aL3 8aRL j@3
cCLnIjCRN s3a3 ICN30 jR 3,@ jR j@3 +­ R8 j@3 3uU3aCL3NjI R$3ICN ,awcjI cjan,jna3. T/#
B/- SbHO. 3u,In0CN< j@3 KR0HRRU 8Cjj30 LCccCN< a3cC0n3c- SĢ: N0 SlkĢSleY QNIw j@3
nN,RNcjaCN30 UaR0n,jCRN anNc a3 c@RsNY 2,@ `Kb/ Cc c@RsN sCj@ II 0j CN j@3 IC<@j3a
,RIRna. sCj@  S Nc aRIICN< q3a<3 Rq3aIC0 CN j@3 0aG3a ,RIRnaY i@3 wAuCc anNc 8aRL z jR
j@3 LuCLnL `Kb/ 8Ra j@j cCLnIjCRNY
Figure S7: RMSD of the C↵ atoms in h175n.
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7C<na3 Yf- `Kb/ R8 j@3 +­ jRLc CN rSeO7Y 7Ra 3,@ UaRjRNjCRN cjj3 ,aRcc j@3
9z Nc R8 3,@ a3UIC,j3Y `Kb/ sc ,I,nIj30 8j3a j@3 +­ R8 3,@ 8aL3 8aRL j@3
cCLnIjCRN s3a3 ICN30 jR 3,@ jR j@3 +­ R8 j@3 3uU3aCL3NjI R$3ICN ,awcjI cjan,jna3. T/#
B/- SbHO. 3u,In0CN< j@3 KR0HRRU 8Cjj30 LCccCN< a3cC0n3c- SĢ: N0 SlkĢSleY QNIw j@3
nN,RNcjaCN30 UaR0n,jCRN anNc a3 c@RsNY 2,@ `Kb/ Cc c@RsN sCj@ II 0j CN j@3 IC<@j3a
,RIRna. sCj@  S Nc aRIICN< q3a<3 Rq3aIC0 CN j@3 0aG3a ,RIRnaY i@3 wAuCc anNc 8aRL z jR
j@3 LuCLnL `Kb/ 8Ra j@j cCLnIjCRNY
Figure S8: RMSD of the C↵ atoms in w179f.
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7C<na3 Ye- `Kb/ R8 j@3 +­ jRLc CN vSOz7Y 7Ra 3,@ UaRjRNjCRN cjj3 ,aRcc j@3
9z Nc R8 3,@ a3UIC,j3Y `Kb/ sc ,I,nIj30 8j3a j@3 +­ R8 3,@ 8aL3 8aRL j@3
cCLnIjCRN s3a3 ICN30 jR 3,@ jR j@3 +­ R8 j@3 3uU3aCL3NjI R$3ICN ,awcjI cjan,jna3. T/#
B/- SbHO. 3u,In0CN< j@3 KR0HRRU 8Cjj30 LCccCN< a3cC0n3c- SĢ: N0 SlkĢSleY QNIw j@3
nN,RNcjaCN30 UaR0n,jCRN anNc a3 c@RsNY 2,@ `Kb/ Cc c@RsN sCj@ II 0j CN j@3 IC<@j3a
,RIRna. sCj@  S Nc aRIICN< q3a<3 Rq3aIC0 CN j@3 0aG3a ,RIRnaY i@3 wAuCc anNc 8aRL z jR
j@3 LuCLnL `Kb/ 8Ra j@j cCLnIjCRNY
Figure S9: RMSD of the C↵ atoms in y190f.
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5 Water-mediated hydrogen bonding interactions in the
binding sites
We also observed water-mediated hydrogen bonding interactions in the binding sites.For the
1:(N7H) and deprotonated coelenterazine (1 ) simulations we saw the consistent involve-
ment of a water molecule hydrogen bonded with the hydroxy group of Tyr190, the imidazole
ring of His175, Trp179 indole nitrogen, and the O10 oxygen of coelenterazine. This inter-
action was always seen to be occupied throughout each simulation. The only di↵erence in
this interaction between mutants was the absence of one of the four amino acids from the
network when they were mutated to a non-polar residue. This bound water was present, but
the hydrogen bonding network surrounding it was reduced for 1 ·[His175]+ ion pair and the
1:(O10H)-coelenterazine simulation. Tyr179 interacted less in these protonation states. A
second persistent water was involved with the N1-nitrogen of coelenterazine. On its own the
N1-nitrogen was hydrogen bonded with Tyr138 for most simulations. This interaction also
occurred in parallel with the second consistent water. This bound water was also observed
to link the N1-nitrogen with His64 and Trp114. Another water mediated hydrogen bond was
observed between the N1-nitrogen and Tyr190 from the catalytic triad. This interaction was
only seen in the 1:(O10H) and 1 ·[His175]+ ion pair simulations. It was observed in these
case for all mutants with the exception of h175n, the two Tyr138 mutants in the ion pair
simulation, and the obvious exclusion, y190f. This N1-Tyr190 linking water molecule was
found in the approximate location of the peroxide moiety in the obelin crystal structure.8–10
This in turn could have an e↵ect on the energetics and geometry of oxygen binding.
6 O2 binding site in obelin
The O2 binding sites identified by the ILS calculations for wt, y138f, y138w, h175n,
w197f and y190f are shown in Figures S10 to S15. The binding modes and energies
are similar among di↵erent obelin (wild-type vs mutants). The binding free energies are
summarized in the maintext Table 1. Similar to what has been discussed about 1sl9 in
the maintext, all four tautomeric/protonation states presented a binding mode above the Re
16
face of the imidazopyrazinone ring, which is the closest to the C2 carbon, the site of oxygen
addition during bioluminescence.
17
Figure S10: The key oxygen binding sites identified in wt. Pictured is the -10.0 kJ mol 1
binding free energy surface for each of the simulated protonation states. Two di↵erent
orientations are shown. (a): the 1:(N7H) state; (b): the 1:(O10H) state; (c): the 1 
state; (d): the 1 ·[His175]+ ion pair state.
18
Figure S11: The key oxygen binding sites identified in y138f. Pictured is the -10.0 kJ
mol 1 binding free energy surface for each of the simulated protonation states. Two di↵erent
orientations are shown. (a): the 1:(N7H) state; (b): the 1:(O10H) state; (c): the 1  state;
(d): the 1 ·[His175]+ ion pair state.
19
Figure S12: The key oxygen binding sites identified in y138w. Pictured is the -10.0 kJ
mol 1 binding free energy surface for each of the simulated protonation states. Two di↵erent
orientations are shown. (a): the 1:(N7H) state; (b): the 1:(O10H) state; (c): the 1  state;
(d): the 1 ·[His175]+ ion pair state.
20
Figure S13: The key oxygen binding sites identified in h175n. Pictured is the -10.0 kJ
mol 1 binding free energy surface for each of the simulated protonation states. Two di↵erent
orientations are shown. (a): the 1:(N7H) state; (b): the 1:(O10H) state; (c): the 1  state;
21
Figure S14: The key oxygen binding sites identified in w179f. Pictured is the -10.0 kJ
mol 1 binding free energy surface for each of the simulated protonation states. Two di↵erent
orientations are shown. (a): the 1:(N7H) state; (b): the 1:(O10H) state; (c): the 1  state;
(d): the 1 ·[His175]+ ion pair state.
22
Figure S15: The key oxygen binding sites identified in y190f. Pictured is the -10.0 kJ
mol 1 binding free energy surface for each of the simulated protonation states. Two di↵erent
orientations are shown. (a): the 1:(N7H) state; (b): the 1:(O10H) state; (c): the 1  state;
(d): the 1 ·[His175]+ ion pair state.
23
7 Potential energy diagram of the four main O2 migration
pathways in Y138W 1:(N7H)
As noted in the maintext, the potential energy diagrams for all the simulated systems are
qualitatively similar and for comparison here we show the diagram for Y138W 1:(N7H),
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R. D. Skeel, L. Kalé, and K. Schulten, J Comput Chem 26, 1781 (2005).
5. A. D. MacKerell, Jr, D. Bashford, M. Bellott, R. L. J. Dunbrack, J. D. Evanseck, M. J.
Field, S. Fischer, J. Gao, H. Guo, S. Ha, et al., J Phys Chem B 102, 3586 (1998).
6. W. L. Jorgensen, J. Chandrasekhar, J. D. Madura, R. W. Impey, and M. L. Klein, J
Chem Phys 79, 926 (1983).
7. J. M. Damas, A. M. Baptista, and C. M. Soares, J Chem Theory Comput 10, 3525
(2014).
8. L. Deng, S. V. Markova, E. S. Vysotski, Z.-J. Liu, J. Lee, J. Rose, and B.-C. Wang
(2004), PDB entry: 1SL9.
9. Z.-J. Liu, E. S. Vysotski, E. S. Vysotski, C.-J. Chen, J. P. Rose, J. Lee, and B.-C. Wang,
Protein Sci 9, 2085 (2000).
10. Z.-J. Liu, E. S. Vysotski, L. Deng, J. Lee, J. Rose, and B.-C. Wang, Biochem Biophys
Res Commun 311, 433 (2003).
26
